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Introduction: Telemedicine use in addiction treatment and recovery services is limited. Yet, because it removes
barriers of time and distance, telemedicine offers great potential for enhancing treatment and recovery for people
with substance use disorders (SUDs). Telemedicine also offers clinicians ways to increase contact with SUD patients
during and after treatment.
Case description: A project conducted from February 2013 to June 2014 investigated the adoption of telemedicine
services among purchasers of addiction treatment in five states and one county. The project assessed purchasers’
interest in and perceived facilitators and barriers to implementing one or more of the following telemedicine modalities:
telephone-based care, web-based screening, web-based treatment, videoconferencing, smartphone mobile applications
(apps), and virtual worlds.
Discussion and evaluation: Purchasers expressed the most interest in implementing videoconferencing and smartphone
mobile devices. The anticipated facilitators for implementing a telemedicine app included funding available to pay for
the telemedicine service, local examples of success, influential champions at the payer and treatment agencies, and
meeting a pressing need. The greatest barriers identified were: costs associated with implementation, lack of reimbursement
for telemedicine services, providers’ unfamiliarity with technology, lack of implementation models, and confidentiality
regulations. This paper discusses why the project participants selected or rejected different telemedicine modalities and
the policy implications that purchasers and regulators of addiction treatment services should consider for expanding
their use of telemedicine.
Conclusions: This analysis provides initial observations into how telemedicine is being implemented in addiction services
in five states and one county. The project demonstrated that despite the considerable interest in telemedicine,
implementation challenges exist. Future studies should broaden the sample analyzed and track technology
implementation longitudinally to help the research and practitioner communities develop a greater understanding of
technology implementation trends and practices.
Keywords: Technology implementation, Health information technology, Substance use disorders treatment, Payer
strategiesIntroduction
Telemedicine applications (apps) that exchange health
information from one location to another create new
connections between treatment providers and their pa-
tients. In general health care, telemedicine is giving pa-
tients a sense that their illness is being monitored more
closely, the ability to participate in their own health* Correspondence: todd.molfenter@chess.wisc.edu
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unless otherwise stated.management, and a feeling they have not been forgotten
by their doctor [1].
The addiction treatment field offers a promising set-
ting for telemedicine use. The chronic nature of addic-
tion disorders calls for methods for clinicians to stay
connected with patients over extended periods of time.
Face-to-face contacts between patients and clinicians are
limited to scheduled appointments or group sessions.
Counselors are not available when they’re most needed:
outside the treatment setting, where patients make deci-
sions to stay sober or not. Telemedicine extends the pro-
viders’ availability and offers patients an immediate
resource.ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ment service by removing the barriers of geography and
stigma [2]. Patients in rural areas who in the past had to
drive long distances can now receive addiction services
within their own homes or at a local health care pro-
vider. Through telemedicine, patients can also avoid
experiencing the perceived stigma of being identified as
a patient at a specialty addiction treatment provider. In
practice, a variety of electronic modalities are increasing
the use of telemedicine in addiction treatment and re-
covery. The most mature modality, telephone-based
care, has been used to provide continuing care for sub-
stance use disorders (SUDs) [3]. Continuing care deliv-
ered by telephone is easy to implement and does not
carry additional costs such as licensing fees or patient
training. Telephone-based services have included tele-
phone monitoring, feedback, and counseling. Study re-
sults for telephone-based continuing care are mixed, but
generally show better results than traditional continuing
care [4–6].
An enhanced application of telephone-based technol-
ogy is interactive voice recognition (IVR) technology. In
IVR, an automated telephone system provides patients
with different follow-up and feedback options based on
their responses to pre-established questions [7]. This
technology has been tested in primary care settings with
mixed therapeutic results [7, 8]. IVR tested in pilot studies
in specialty treatment settings reduced post-outpatient
treatment drinking days per week, but only for patients
who had achieved treatment goals at time of discharge [9].
Web-based telemedicine services are accessible to many
patients and are typically “asynchronous,” meaning that
people can access them any time, at their convenience.
Several web-based platforms and apps for SUD assess-
ment are available [10, 11]. Overall, web-based telemedi-
cine services have been found to be more effective at
reducing alcohol consumed per week than comparison
conditions [12, 13]. This is particularly true for nonstu-
dent populations [12]. One population, subcritically in-
jured trauma patients, has not had positive results with
web-based telemedicine [14].
For web-based alcohol screening, assessment, and feed-
back or brief intervention, the Drinker’s Check-up (DCU)
has demonstrated positive results in several clinical trials
[10, 15]. The DCU (www.drinkerscheckup.com) is an inte-
grated computerized system that includes Moderate
Drinking (moderatedrinking.com), a web app for people
who want to reduce their drinking, along with several
other components: a) a brief screening that utilizes the
Alcohol Use Disorders Identification Test (AUDIT); b) an
in-depth assessment; c) a full motivational session tailored
to the individual’s assessment results; and d) computerized
cognitive treatment options that link to web-based mutual
aid groups. Similarly, web-based, computerized, briefinterventions for drug use demonstrate results similar to
or better than clinician-delivered services [16].
An example of a web-based SUD treatment is the
Therapeutic Education System (TES) [17]. TES consists
of 65 modules based on the Community Reinforcement
Approach (CRA) and includes modules on HIV/STD pre-
vention. TES is provided in conjunction with clinician-
delivered services and serves as a clinician extender.
Research studies are demonstrating superior outcomes for
patients using TES compared to treatment as usual. Re-
search studies are also showing TES results comparable to
those for the CRA delivered in person by highly trained
clinicians [18].
Another web-based treatment approach that has been
examined in research studies is Computer-Based Treat-
ment for Cognitive Behavioral Therapy (CBT4CBT) [19].
Research studies have shown positive outcomes (similar to
the TES studies) with CBT4CBT compared to treatment as
usual or treatment provided solely by clinicians [17, 20].
Videoconferencing for addiction treatment or psychiatry
occurs through secure portals on personal computers or
dedicated telemedicine consoles. Videoconferencing is cur-
rently used in addiction services for: a) video therapy,
where patients can interact with clinicians from a remote
location or the privacy of their homes; b) recovery sup-
ports, where a counselor or peer-support specialist inter-
acts with a person in recovery; and c) specialty services,
where patients are placed in contact with hard-to-reach
medical specialists, such as an adolescent psychiatrist or a
physician who can prescribe buprenorphine. Studies in vid-
eoconferencing for addiction services have found no differ-
ence in the results or patient satisfaction of care provided
in person or by video [21, 22]. Meta-analyses of videocon-
ferencing for psychiatry services have found similar posi-
tive results [23, 24], with the notable exception that neither
in-person nor video services affected outcomes for post-
traumatic stress disorder patients [25].
Mobile devices (smartphones and tablets) make sub-
stance abuse treatment and recovery support available
24 h a day, 7 days a week. An early meta-analysis of mo-
bile device use in overall health care determined that it
is too early to pool effects of this technology, and that
the positive effects that have been realized are primarily
attributed to texting interventions within the mobile de-
vice apps [26]. Smartphones and tablets offer the same
services as telephone-based, web-based, and videocon-
ferencing services. The Addiction Comprehensive Health
Enhancement Support System (A-CHESS) app has been
found to reduce risky drinking days and to achieve
higher abstinence rates than usual care [27]. A-CHESS
has also been a useful tool for alcohol relapse prevention
for patients following discharge from residential services
[28]. A-CHESS is delivered through a smartphone and
contains the following key features: a secure discussion
Table 1 Telemedicine modalities & products
Telemedicine modality Products
Telephone-Based Care
Post-Treatment Supports Telephone-Based Continuing Care Program






Screening, Brief Intervention, and Referral to
Treatment (SBIRT) [40]




Videoconferencing Dedicated videoconferencing equipment or
video interface on personal computer with




Virtual Worlds and Avatars Virtual worlds developed by Innovation or
Second Life
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vides supportive information; individualized reminders of
reasons to not use; automatic messages requesting assist-
ance from people identified as supportive of the patient’s
recovery; a GPS-enabled function that sends a warning if a
patient is approaching a previously identified high-risk
location; a daily check-in assessment of substance use; and
a mutual-aid meeting locator. A weekly survey of recovery
risk and protection factors is also pushed through the
phones, with graphs showing changes over time. Coun-
selors have access to the daily check-in assessment and
weekly survey results. Another mobile app called Location-
Based Monitoring and Intervention System for Alcohol
Use Disorders (LBMI-A) has reduced hazardous drinking
days and drinks per day [29]. This app provides numerous
features, similar to A-CHESS, for intervening with ongoing
drinking, craving, connecting with supportive others, man-
aging life problems, high-risk location alerting, and activity
scheduling.
Virtual worlds are an ongoing, synchronous (or real-
time) environment facilitated by networked computers
that provide a “virtual” social space where people inter-
act and are represented by avatars [29]. Avatars are
graphic representations of users that users build with
tools supplied in the computerized environment. Users
can then control their avatars to interact with others av-
atars within the virtual environment. Research on virtual
reality in addiction treatment that predates virtual
worlds and does not allow for synchronous social inter-
action has established that computer-generated, 3-D en-
vironments can simulate reality effectively and provide
settings for testing reactions to environmental triggers
for craving [30–32].
Virtual worlds and avatars have been used in recent years
to address SUDs. Companies design these virtual environ-
ments for specific treatment organizations; the resulting
virtual world is protected and available only to people with
an access code and a password. Services within the virtual
worlds may include presentations, individual or group
counseling, and a live clinician who interacts with the pa-
tients through an avatar. Thus, the virtual world allows
synchronous communication between SUD patients and
clinicians. To our knowledge, no research studies on the
use of virtual worlds to address substance use have been
completed; however, early adopters of telemedicine tech-
nology in addiction services are considering this option,
even though it currently lacks an evidence base.
Case description
Case background
In 2011, less than 1% of addiction treatment providers
were using telemedicine [33]. Recognizing the increased
use of telemedicine in general medicine and the oppor-
tune environment for expanding telemedicine services inaddiction treatment and recovery, the Substance Abuse
and Mental Health Services Administration’s (SAMHSA)
Strengthening Treatment Access and Retention State Ini-
tiative (STAR-SI) developed a technical assistance program
for states interested in using telemedicine for addiction
treatment. During 2013–14, the NIATx national program
office at the University of Wisconsin-Madison delivered
technical assistance focused on providing systems-level
and organization change technical assistance to single
state authorities (SSAs) and other payers who oversee dis-
tribution of state and federal funding for substance abuse
treatment programs. The program included five states and
one county participant, selected through a competitive re-
view of applicants’ plans for adopting telemedicine. The
project served as a real-world laboratory for observing the
telemedicine apps that generated the most interest among
the participants and for identifying the facilitators and bar-
riers affecting implementation of these apps.
Case design
Five states (Iowa, Maryland, Massachusetts, Oklahoma,
South Carolina) and one county (San Mateo, California)
participated. Each participant reviewed a list of telemedi-
cine apps to consider for implementation or expanded
use, if implementation had already occurred (Table 1).
The list was developed by applying publicly, available
evidence-based, patient-interactive technologies used in
addiction services and nonevidence-based technologies
specifically requested by the states. Use of virtual worlds
with avatars was the only nonevidence-based technology
that states requested. From this list, each state developed
a short list of telemedicine modalities to consider for im-
plementation or expanded use. Then, with the technical
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modalities to pursue; b) listed the anticipated benefits of
the selected telemedicine modalities; and c) developed a
plan for implementing or expanding use of the selected
telemedicine apps within their state or county, with con-
sideration of anticipated facilitators and barriers to
implementing or expanding use.
Measures
For state and county characteristics for participants, the
volume of SUD providers and SUD clients served indi-
cates the size of the participant’s provider networks. The
baseline telemedicine environment is described by listing
the existing telemedicine modalities present, their func-
tions, level(s) of care, and levels of implementation. The
study statistics include a listing of telemedicine modalities
that the participants selected and the expected benefits of
using each modality, as well as the anticipated facilitators
and barriers to implementation and expansion.
Data collection and analysis
State volume statistics were collected through the National
Survey of Substance Abuse Treatment Services 2011 data-
set [34]. The baseline telemedicine capacity, the telemedi-
cine modalities considered, the telemedicine modalities
selected, and the listing of assets and barriers to implemen-
tation were collected through monthly reports. During the
course of the project (February 1, 2013–June 31, 2014),
technical assistance coaches generated monthly reports
documenting participant activities. The coaches interacted
with the states and county at least once monthly, as they
assisted them in telemedicine implementation and expan-
sion. Eisenhardt’s iterative Process of Building Theory from
Case Study Research [35] was used to document modality
selection as well as facilitators and barriers listed.
Findings
Variation existed in the number of treatment providers lo-
cated in each state/county. Maryland had the greatest
number of providers, with 362, and San Mateo County
had the least, with 25 providers. The number of treatment
facilities in South Carolina was 102; there were 145 in
Iowa, 218 in Oklahoma, and 328 in Massachusetts. These
statistics represent total volume of providers, and are not
reflective of the number of users of a certain telemedicine
app. Massachusetts had the greatest number of outpatient
admissions (45757), and San Mateo had the fewest out-
patient admissions (2450). Outpatient admissions from
the remaining locations were numbered as follows: South
Carolina (13919); Iowa (8663); Oklahoma (16890); and
Maryland (39080).
At baseline, telemedicine activity was occurring in four
of the six locations (Table 2). Three of Iowa’s facilities
were using telephone-based care for treatment andrecovery services. Fourteen of Iowa’s 145 facilities were
implementing the Recoveration website. This is a pre-
programmed website that treatment agencies implement
to provide informational supports and counseling services
to their consumers. Oklahoma’s e-Psychiatry (or psychi-
atric videoconferencing) program that services mental
health and SUD patients experienced 120000 visits in
2013. Maryland and Massachusetts both had innovative
pilots experimenting with virtual worlds and smartphones,
respectively.
Through the project, participants had the opportunity
to enhance the provision of telemedicine within their ju-
risdictions, and several participants selected more than
one technology to pursue. The technologies that gener-
ated the greatest interest were videoconferencing (n = 4
states) and smartphone mobile devices (n = 3 states)
(Table 3). The primary benefits identified for videoconfer-
encing were access to services for rural patients and access
to physicians who can prescribe Suboxone® for treatment
of opioid dependence. The primary benefit identified for
smartphone mobile devices was the ability to reach indi-
viduals in treatment and recovery outside the treatment
setting. None of the participants chose to adopt or expand
use of virtual worlds or telephone-based continuing care.
Upon selection of a modality, participants were asked
to identify projected facilitators and barriers to adoption
of the chosen modality. Perceived facilitators of tele-
medicine use included having a strong champion, having
resources to pay for start-up costs, having established re-
imbursement mechanisms for telemedicine services, and
existing examples of the telemedicine being applied lo-
cally or nationally (Table 4). Conversely, participants
identified initial and continuing funding for telemedicine
services as the greatest barrier to implementation. Other
barriers listed included provider and patient resistance,
confidentiality concerns, and the absence of implemen-
tation models.
Discussion and evaluation
Purchasers of addiction treatment services in this project
had an interest in using telemedicine modalities in addic-
tion treatment. The modalities that seemed to create the
greatest interest were those that were perceived as readily
embraced by treatment providers and their patients.
Level of research findings and their role in
decision-making
Meta-analyses support the use of telephone-based con-
tinuing care, [5] web-based addiction treatment interven-
tions [12, 13], video-based telemedicine [36], and even
smartphone use in mental health [37]. A weakness in
these meta-analyses is that they pool studies conducted by
the developers. In selecting technologies to consider, the
states wanted to know the results of specific products and
Table 2 Baseline telemedicine activities
State Technology Function Level of care Level of Implementation
(at Baseline)
IA • Telephone-based care
(McKay’s Model)
• Facilitate distance treatment
services for problem gambling
and substance use disorders.
• Outpatient Treatment
(Level I.0 and Level II.1)
Implemented in 14 state-funded









○ Relapse Prevention○ Smartphone version of
www.Recoveration.org ○ Continuing Care
○ Family Education
MD Virtual World Provide access to treatment
services
• Outpatient Treatment
(Level I.0 and Level II.1)
A pilot (n=7 providers) underway





MA Smartphone Mobile Device
with A-CHESS
• Provide access to recovery
support information anytime,
anywhere
• Includes: 4 treatment providers in state were











(Level I.0 and Level II.1)
Conducted 120,000 visits in 2013
San Mateo None
South Carolina None
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in academic settings. However, the states usually wanted to
talk to other users of the product and use the product
themselves before forming their overall opinions of the
technology. The lack of an evidence base for virtual worlds
and other considerations affected how the states viewed
this modality.
Other reasons for modality selection
Use of videoconferencing was attractive because it met a
specific need: to provide access to a scarce medical resour-
ce—buprenorphine (Suboxone), in geographic areas that
lack physician prescribers. Videoconferencing was also
used in South Carolina to increase access to adolescent
psychiatrists in remote or rural areas.
Use of smartphone mobile devices was attractive for a
variety of reasons: the apparent low entry costs of equip-
ping patients who already have mobile phones with mobile
apps; the ability to create a valuable ongoing relationship
with a patient using mobile apps; and the research evi-
dence of their effectiveness [27].
Implementation considerations
The project identified several issues to consider when
implementing telemedicine technology. Among them isthe fact that the substance use treatment field lags behind
general health care in the use of non-electronic health rec-
ord (EHR) technologies [33]. As a result, participants in
the project experienced a significant learning curve, as
they were either just beginning to investigate technology
or were in the early stages of implementation.
Implementing technology also changes the traditional
workflow, as well as the roles and functions of clinical
staff members. Accordingly, treatment organizations will
need to develop new workflows and overcome clinical
resistance to these changes.
Cost is a significant challenge that states, counties, and
providers face in implementing telemedicine. First, start-
up costs can be an issue. Despite initial interest, virtual
worlds or web-based treatment systems were perceived as
too costly to purchase and operate and were not pursued.
Second, reimbursement for basic telemedicine services
varies broadly between state Medicaid systems and private
insurers, with many not reimbursing for these services.
An additional consideration for telemedicine use in-
volves protecting patient anonymity and compliance
with the Health Insurance Portability and Accountability
Act (HIPAA) and the 42 Code of Federal Regulations
(CFR) Part 2 [38]. HIPAA protects the confidentiality
and security of health care information. The more
Table 3 Telemedicine modalities and benefits
Payer Modalities Considered Modalities Selected Anticipated Benefits
Iowa 1) Web-based Computerized Treatment
System (Recoveration)
Web Portal (Recoveration) Rural access
Greater engagement
Maryland 1) Videoconferencing Videoconferencing (telesuboxone) Address opiate epidemic
2) Virtual Worlds Greater access to physician prescribers
Massachusetts 1) Psychiatric videoconferencing (e-Psychiatry) Mobile Device (A-CHESS) Provision of Recovery Support
2) Virtual Worlds Web Screening (College Drinker’s
Check-up)
Tertiary prevention and harm reduction
among college students
3) Smartphone Mobile Device (A-CHESS)
4) Web-based Computerized Treatment
System (TES)
5) Web Screening (SBIRT and Drinker’s
Check-up)
Oklahoma 1) Smartphone Mobile Devices (A-CHESS) Smartphone Mobile Device (A-CHESS) Greater engagement and extension
of recovery support












Videoconferencing (telesuboxone) Greater access to physician prescribers
South Carolina 1) Videoconferencing (psychiatry) Videoconferencing (psychiatry) Addressing identified disparities in
access to specialized SUD care
2) Smartphone Mobile Devices (A-CHESS) Smartphone
3) Web Based Computerized Treatment
(Brief Intervention)
Mobile Devices (A-CHESS)
4) Virtual Worlds Improving collaboration between
community partners
Provision of mobile recovery support
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alcohol and drug abuse patient records. Both regulations
present an additional challenge when using technology,
because no accreditation system documents that a tele-
medicine system is in compliance. Prospective users
must carefully evaluate whether or not the services meet
the requirements of these regulations.
State/county payer and regulatory policy considerations
The participants and the study team considered policies
that could promote or hinder the use of the telemedicine
modalities piloted in this project.
Telephone-based services
There are no licensing, purchasing fees, or equipment
costs associated with telephone-based services. The only
potential costs are long-distance or cell phone service
charges. Clinical staff would need training in delivering
brief focused clinical sessions if the telephone-based con-
tinuing care model is adopted.
Since telephone-based services involve synchronous
(real-time) communication between the clinician andthe patient(s), existing individual, group, or case man-
agement payment rates could be used for reimburse-
ment. Only policy or rule changes would be required to
extend coverage to telephone-based services. For example,
Iowa currently reimburses for telephone-based counseling
sessions through Substance Abuse Prevention and Treat-
ment block grant funds.Web-based treatment
The lack of payment mechanisms to support the costs of
using web-based treatment systems is a major barrier to
their adoption by specialty substance use treatment or-
ganizations. Because their use involves asynchronous
(not in real time) use by the patient, without the imme-
diate involvement of a clinician, the services do not fit
the existing fee-for-service reimbursement system. Yet,
there are costs to an organization for using computer-
ized treatment, including annual licensing fees, training
patients on the use of a system, providing ongoing sup-
port as needed, and the clinical time needed to monitor
progress reports generated by the system.
Table 4 Anticipated facilitators and barriers
State Technology Facilitators Barriers
Iowa Web-based Computerized Treatment
(Recoveration)
Initial funding through SAMSHA TCE Grant Agency concerns with technology
NIATx Improvement Collaborative Agency inexperience with technology
Treatment agency champion
Massachusetts Smartphone Mobile Device
(A-CHESS)
Existing example of successful
application (A-CHESS)
Identifying start-up funding
Web Screening (Drinkers Check-up) Potential case rate funding model Lack of funding for reimbursement
Concerns with meeting HIPAA &
42CFR regulations
Maryland Videoconferencing (telesuboxone) Strong champion (state governor) Lack of willing and available MDs for
suboxone prescribing
Limited funding for reimbursement
Limited models to follow
Oklahoma Smartphone Mobile Device
(A-CHESS)
Smartphone Mobile device start-up
funding is available
Limited reimbursement model
Expanded Videoconferencing Medicaid expansion covered clinical
services for videoconferencing
San Mateo County Videoconferencing (telesuboxone) Demonstrated need for greater MD
coverage to address opiate addictions
Competing priorities
(ACA implementation)
Lack of start-up funding
Lack of funding for reimbursement
HIPAA compliance concerns
South Carolina Videoconferencing (telepsychiatry &
telesuboxone)
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and future studies show a cost benefit and lower costs per
episode of care in using the web-based systems, states
may start to experiment with reimbursement models that
cover the costs.
Videoconferencing
Several policy issues also need to be considered for vid-
eoconferencing. First, because platforms are proliferating
(and claim to be HIPAA compliant), selecting a platform
can be daunting. Second, interstate regulation—when the
patient and the counselor are videoconferencing from dif-
ferent states, determining which state regulates the trans-
action can become complicated. Typically, the state where
the patient is located becomes the licensing authority.
Hence, the counselor or physician will need to carry a li-
cense from the state where the patient is located. Third, at
least one state, Florida, offers a certification program for
counselors who provide treatment using distance tech-
nologies: Certified E-Therapists. Florida’s Certification
Board selected the Online Therapy Institutes’ training pro-
gram. Most states, however, allow licensures achieved for
the delivery of in-person clinical care to apply to video
care. Lastly, states must allow clinicians providing servicesthrough videoconferencing to be reimbursed for those
services.Smartphone mobile devices
The lack of payment mechanisms to support services deliv-
ered through smartphone mobile devices is a major barrier
to their adoption by specialty substance use treatment or-
ganizations. Several A-CHESS features use asynchronous
technology that does not provide a clinical therapy session.
Therefore, the services do not fit the fee-for-service reim-
bursement system. Costs to an organization for using
smartphone mobile devices include annual licensing fees,
training patients and staff on the use of a system, providing
ongoing support as needed, and the clinical time needed to
monitor progress reports generated by the system. Another
potential cost, providing smartphones to those who do not
have access to them, could result in the cost of providing
smartphones and service plans. Fortunately, in some set-
tings carriers and vendors have developed special programs
for low- or no-cost services that states, counties, and pro-
viders can use to increase access to mobile devices and
data plans. As mobile smartphones and computer tablets
become more and more ubiquitous, the services could be
Molfenter et al. Addiction Science & Clinical Practice  (2015) 10:14 Page 8 of 9delivered more affordably to people who have the smart-
phone mobile devices and adequate service plans.
Virtual worlds
Initial costs are an impediment to use of virtual worlds,
with implementation cost estimates ranging from $10,000
to $100,000. Few provider organizations can afford costs
in the higher range; nor are states likely to support such
expensive upfront investments.
Existing virtual worlds such as Second Life could be uti-
lized with lower costs. Second Life will lease use of a vir-
tual “island” that only allows access to those with pass
codes. The island has no features, so the environment still
has to be created. Second Life provides tools for creating
an environment, requiring support from someone with
the development knowledge and skills. Also, a person
using Second Life can access all but the closed environ-
ments, and many existing Second Life environments, such
as bars and parties, are not conducive to recovery support.
Since use of the technology involves synchronous (or
real-time) communication between the clinician and the
patient(s), existing individual and group session payment
rates could be used for reimbursement. However, policy
or rules would have to be changed to extend coverage to
these services.
Limitations
The analysis has limited generalizability, as it describes
the experience of only five states and one county. Yet,
the findings offer insights into how purchasers of addic-
tion treatment services are viewing the use of telemedi-
cine for addiction treatment.
Another limitation is that the A-CHESS app was devel-
oped by the Center for Health Enhancement Systems
Studies at the University of Wisconsin-Madison, where
the lead author holds an academic appointment. This
could have resulted in natural biases or conflicts of inter-
est regarding this smartphone app. It should be noted,
however, that since completion of the state project re-
ported in this study, another evidence-based smartphone
app, the LBMI-A [29], has emerged that has many of the
same functions as A-CHESS. Hence, the authors propose
that the findings related to the states’ interest in the
A-CHESS smartphone app may not be product-specific
(e.g., A-CHESS) and could be generalized to smartphone
apps with similar functionality.
Moreover, not all possible telemedicine apps are ad-
dressed. The number of nonevidence-based smartphone
mobile apps available for addiction treatment is growing
rapidly. Text messaging was included as part of discus-
sions related to smartphone mobile apps and web por-
tals, since these modalities offer that feature. Text
messaging should have been discussed as a stand-alone
option because it is an accessible, low-cost approach fororganizations to provide consumer support, automated
content, and reminders [39].
In sum, this analysis would be more complete with:
a) inclusion of a greater number of states and territories,
b) a larger range of telemedicine modalities, and c) consid-
eration of different implementation models and challenges
specific to the different technological modalities and envir-
onmental contexts related to institutional settings, reim-
bursement policy, and levels of care.Conclusions
This project did demonstrate considerable interest in tele-
medicine; facilitators in some states exist; and implementa-
tion barriers can interrupt best intentions. These barriers
begin with reimbursement challenges at the system level
and continue with resistance to using targeted telemedicine
at the provider and patient levels. The multilevel nature of
telemedicine implementation calls for multilevel models to
explain and predict technology adoption.
Finally, new technologies are emerging as potential tools
for preventing and addressing addiction. The rapid growth
of new technologies requires continual examination of tele-
medicine technologies to track their use in general addic-
tion treatment practice.
Telemedicine will inevitably play a greater role in addic-
tion treatment and recovery services. Yet, technologies that
become part of standard practice will likely be a result of
considerations of the technology’s costs, perceived benefits,
and ease or difficulty of implementation.
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